Objective
Carcinomas of the colon and rectum are the third leading cause of cancer-re
lated deaths. Although advances in the surgical treatment of primary colore
ctal cancers have lead to improvements in patient survival at early tumor s
tages, treatment of more progressive cancers has not resulted in dramatic i
mprovements in patient survival. However, the selection of patient subgroup
s based on their prognosis and other characteristics could result in improv
ed outcomes from adjuvant therapies in patients with Dukes B and C carcinom
as.
Methods
The authors reviewed the available data on the value of cell surface molecu
les in assessing the prognosis of colorectal carcinomas, paying specific at
tention to the evaluation of statistical analysis and multivariate procedur
es.
Results
Cell surface molecules have been identified on colorectal carcinoma cells w
hose expression appears to be related to malignant transformation, tumor pr
ogression, or patient prognosis. Among these cell surface molecules, variou
s cell adhesion molecules, growth factor receptors, proteinases, and their
receptors and inhibitors have been identified as potentially useful prognos
tic markers,
Conclusions
Although data exist on the prognostic values of certain cell surface marker
s, the use of multivariate analysis for the identification of valuable prog
nostic factors remains uncommon. Using reproducible and standardized multiv
ariate analysis procedures, new tumor markers should be carefully examined
for their biologic and prognostic relevance before being considered as pote
ntially useful in the management of colorectal cancers.